相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcome of Single Agent Generic Gemcitabine in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer and Primary Peritoneal Adenocarcinoma
Prapaporn Suprasert et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Molecular mechanisms of the origin of micronuclei from extrachromosomal elements
Noriaki Shimizu
MUTAGENESIS (2011)
Replication Stress Induces Micronuclei Comprising of Aggregated DNA Double-Strand Breaks
Bing Xu et al.
PLOS ONE (2011)
Mechanisms of dNTP supply that play an essential role in maintaining genome integrity in eukaryotic cells
Hiroyuki Niida et al.
CANCER SCIENCE (2010)
Overcoming platinum resistance in ovarian carcinoma
Koji Matsuo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
Andrew J. Massey et al.
PLOS ONE (2010)
Extrachromosomal Double Minutes and Chromosomal Homogeneously Staining Regions as Probes for Chromosome Research
N. Shimizu
CYTOGENETIC AND GENOME RESEARCH (2009)
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small-Cell Lung Cancer
Craig Reynolds et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
H. Akita et al.
ONCOGENE (2009)
Multiple origins of spontaneously arising micronuclei in HeLa cells: Direct evidence from long-term live cell imaging
Xiaotang Rao et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells
Noriaki Shimizu et al.
GENES CHROMOSOMES & CANCER (2007)
Role of gemcitabine in the treatment of ovarian cancer
Fadi AbuShahin et al.
WOMENS HEALTH (2007)
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Shin Nakahira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea
R. Narath et al.
GENES CHROMOSOMES & CANCER (2007)
RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer
Gerold Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene amplification in cancer
Donna G. Albertson
TRENDS IN GENETICS (2006)
Role of gemcitabine in ovarian cancer treatment
D. Lorusso et al.
ANNALS OF ONCOLOGY (2006)
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant
AM Bergman et al.
CANCER RESEARCH (2005)
Oncogenic role of eIF-5A2 in the development of ovarian cancer
XY Guan et al.
CANCER RESEARCH (2004)
Chromosome aberrations in solid tumors
DG Albertson et al.
NATURE GENETICS (2003)
Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumor cells via micronuclear capture of episomes and double minute chromosomes
PV Schoenlein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Selective elimination of acentric double minutes from cancer cells through the extrusion of micronuclei
N Shimizu et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2000)
Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
